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2Abstract:
Endothelial cells are a structural barrier and an active regulator of many bodily
processes. CYP1A activity is induced in the endothelium of teleosts and mammals
exposed to lipophilic xenobiotics, such as polycyclic aromatic hydrocarbons, and can
have significant consequences for endothelial functions. We exposed cultures of
characterized endothelial cells from the heart, kidney and rete mirabile of the eel,
Anguilla rostrata, to AhR agonists.  In heart endothelial cells the maximum response
(based on EROD activity) to TCDD, 113 pmol/mg-min, was at 1 nM TCDD and the peak
response to βNF, 135 pmol/mg-min, was at 3 µM βNF. The maximum response to
TCDD in the kidney endothelial cells is 12 pmol/mg-min at 0.3 nM TCDD. The rete
mirabile capillary endothelial cells responded minimally or not at all to exposure to
TCDD and βNF. Both the heart and kidney endothelial cells (but not the rete mirabile
capillary cells) have a low level of EROD activity (12.7 and 5.2 pmol/mg-min
respectively) in untreated or DMSO-treated cells. The robust response of the heart
endothelial cells to induction and the lack of response in the rete mirabile capillary
endothelial cells indicate that these cells are a good resource to use to investigate the
physiological consequences of AhR agonist exposure and CYP1A induction in different
areas of the vasculature.
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3INTRODUCTION
Endothelial cells that line the vascular systems in vertebrates function as a
structural barrier between the blood and tissues and as an active regulator of many
bodily processes. Compromising the structural barrier affects the exchange of materials,
e.g., gases, solutes or ions, between the blood and tissues. Regulatory functions of
endothelial cells also can be altered by a large number of blood-borne chemicals as well
as mechanical stimuli. Although endothelium is structurally similar throughout the
vasculature not all endothelia respond to the same stimuli. In vivo studies show that
endothelium in different types of vessels or in different organs can differ in specific
regulatory processes as secretion of vasoactive agents (Steinhorn et al.,1993; Gannon
et al.,2000) and cultures of endothelial cells have been used to elucidate many of these
regulatory processes  (Lou et al.,1997; Sadar and Andersson,2001)The endothelium
has also been implicated as the site of origin of pathological processes, i.e.,
atherosclerosis, and the target for diverse toxic or mutagenic agents (Annas et al.,2000;
Dugas et al.,2000). Here we address functional distinctions in endothelial cell response
to toxicants.
Exposure to lipophilic xenobiotics, such as polycyclic aromatic hydrocarbons
(PAH) or planar halogenated aromatic hydrocarbons (pHAH) can produce chronic or
acute responses that are either harmful or protective in vertebrates (Nebert et al.,2000;
Thum et al.,2000; Mimura and Fujii-Kuriyama,2003). For example, exposure to PAH
and pHAH produces a number of responses that include edema (Teraoka et al.,2003),
developmental abnormalities (Guiney et al.,1997; Cantrell et al.,1998), mutagenesis
(Shimada and Fujii-Kuriyama,2004) and altered responses to endogenous signaling
4molecules (Annas and Brittebo,1998; Schlezinger et al.,1998). The effects seen in the
cardiovascular system (e.g., atherosclerosis, edema) may indicate damage to the
endothelial layer (Bayou-Denizot et al.,2000; Hennig et al.,2002b).
Exposure to PAH or pHAH elicit the induction of enzymes of the cytochrome
P4501A (CYP1A) family through the aryl hydrocarbon receptor (AhR) transcription
factor (Hahn,1998; Mimura and Fujii-Kuriyama,2003). The endothelium in many tissues
is rich in AhR expression and responds to xenobiotic exposure with the induction of
CYP enzymes (Stegeman et al.,1987; Stegeman et al.,1989; Smolowitz et al.,1991;
Stegeman et al.,1991). Thus, endothelial cells in tissue sections from mammals and fish
exposed in the environment or in the laboratory show induction of CYP1A enzymes
(Smolowitz et al.,1991; Stegeman et al.,1991; Schlezinger and Stegeman,2000;
Schlezinger et al.,2000b) . Similarly, cultures of mammalian endothelial cells show
induction of CYP1A by pHAH and are being used to study the mechanisms of the
cellular response of the endothelium to xenobiotics (Stegeman et al.,1995; Celander et
al.,1997; Hennig et al.,2002).
The ubiquitous distribution of many PAH and pHAH compounds in marine and
freshwater environments has led to intensive study of how aquatic organisms,
particularly fish, respond to these compounds (Hahn et al.,1998; Schlezinger et
al.,2000b; Schlezinger and Stegeman,2000b). Induction of fish CYP1A by AhR agonists
have been studied in highly exposed natural populations, in laboratory studies of fish
taken from the field, in fish embryos and in fish hepatoma cells (Hahn et al.,1993;
Guiney et al.,1997; Schlezinger and Stegeman,2000b). With the establishment of
methods to maintain and subculture teleost fish endothelial cells (Garrick,2000) we can
5now address questions about effects of xenobiotics on the endothelium that could not
be tested previously.
We report here that endothelial cells isolated from different organs of the eel,
Anguilla rostrata, respond to exposure to PAHs with induction of CYP1A in tissue-
specific ways that reflect the pattern seen in these tissues in vivo.
MATERIALS AND METHODS
Chemicals
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (>98% pure) was obtained from Ultra
Scientific, Hope, RI, USA. 7-Ethoxyresorufin was purchased from Molecular Probes
(Eugene, OR). Dimethylsulfoxide (DMSO), β-napthoflavone (βNF)  and all other
reagents were the highest grade available from Sigma (St. Louis, MO). Cell culture
materials from Sigma were cell culture tested grade. Other sources were noted below.
Isolation and Culture of Endothelial Cells
Healthy, adult female eels were obtained from the Marine Resources Center at
the Marine Biological Laboratory (Woods Hole, MA). Isolation and cell culture was as
described in Garrick,2000. Briefly, the organs were excised, rinsed free of blood and
treated to separate the cells. In the rete mirabile the “heart” and “bladder” poles were
removed which leaves only the capillaries for isolation. The capillaries were digested
enzymatically and plated into T-25 flasks.  The excised heart and kidney were cleaned,
any large vessels removed and the tissue minced and dispersed into T-25 flasks. All
were grown in M199SE [Medium 199 with Earle’s salts and 20 mM NaCl, 20 mM
HEPES, 26 mM NaHCO3  , 0.68 mM glutamine, 10 µM pyruvate 1X antibiotic-antimycotic
6solution (100 U/ml penicillin, 100 µM/ml streptomycin, 2.5 µM/ml amphotericin B), and
50 µg/ml gentamicin] with 20 % serum (Cosmic Calf Serum, fortified (CCS), Hyclone,
Logan, Utah), 20 µg/ml of endothelial cell growth supplement (ECGS) and  50 µg/ml
heparin (Sigma, cell culture tested) in  T-25 Primaria ® flasks coated with 10 µg of
fibronectin and 1 µg/ml of hyaluronic acid (FHA) and incubated at 25 ° C in humidified
air with tightly capped non-vented tops. At confluence the cells were subcultured or
aliquots frozen by standard procedures. All cells used in this study were in passage 1 to
3.
The endothelial origin of the cells was confirmed by the uptake of fluorescently
labeled acetylated low density lipoprotein (DiI-Ac-LDL, 1,1’-dioctadecyl-1-2,3,3’,3’-
tetramethyl-indocarbocyanide perchlorate acetylated LDL, Biomedical Technologies,
Stoughton, MA) (Garrick, 2000). Cells were grown under standard conditions in coated
slide flasks, incubated with DiI-Ac-LDL and viewed with a Zeiss Axiovert S100
fluorescent microscope.
Treatment of Cells
Cells were plated into coated (FHA) 48 well plates (Costar™, Cambridge MA) at a
density of ~5 -10 x 104 cells/well and grown to confluence in 0.5 ml of M199SE with 20
% CCS and ECGS. The plates were sealed with 2 layers of airtight plastic plate sealer
(Secureseal Therm Seal®, Fisher Scientific, Springfield NJ), covered and incubated at
25° C in humidified air. At confluence the medium was removed and the cells were
rinsed with serum – free M199SE and then 0.5 ml of M199SE with 1% CCS was added
to each well. Cell cultures were treated with TCDD or βNF, dissolved in DMSO (Hahn et
al.,1996), or DMSO alone or with buffer as described previously (Stegeman et al.,1995).
7Aliquots (2.5 µl) were added to the wells from dilutions of stock dosing solutions so that
DMSO was present at 0.5% (v/v) in all wells except the untreated cells. Each dose was
added to 6 wells, the plate was shaken for 1 min. and the cultures returned to the
incubator at 25° C in humidified air for 48 hours. The wells were examined
microscopically before and after induction to confirm the cells were confluent and intact.
Induction of cells for microsome preparations was performed in FHA coated T-75 flasks
with a 5 ml of M199SE with 1% CCS with the addition of 25 µl of dosing solution.
Assays
1. EROD activity
The O-deethylation of 7-ethoxyresorufin to resorufin, (EROD) a measure of
CYP1A activity, was determined fluorometrically with a Cytofluor 2300 (Millipore)
multiwell plate reader by procedures described and then modified by (Kennedy et
al.,1995; Hahn et al.,1996; Ganassin et al.,2000).  Modifications of incubation
procedures follow previously published protocols (Hestermann et al.,2000; Hestermann
et al.,2002). At the end of the dosing time the medium was removed and the cells
washed with 0.5 ml of phosphate - buffered – saline (PBS) with HEPES pH 7.5 (0.136 M
NaCl, 8.1 mM Na2HPO4, 1.47 mM K2HPO4, 2.68 mM KCl, 10 mM HEPES).
The EROD reaction was initiated by the addition of 200 µl / well of a solution of 7-
ethoxyresorufin  (2.67 µM in PBS-HEPES at pH 7.8) and monitored kinetically for 20
min. Resorufin standard curves were prepared in PBS-HEPES pH 7.8 in wells in each
plate. At completion of the EROD assay total protein content was measured in each well
with the fluorescamine assay (Lorenzen and Kennedy,1993) with BSA solutions for the
8standard curve. EROD activity was calculated as pmol/mg protein/min of resorufin
produced as described in (Hahn et al.,1996; Ganassin et al.,2000)
2. Preparation of microsomes from endothelial cells
Microsomes were prepared from endothelial cells induced in T-75 flasks. After a
48 hour exposure, the dosing medium was removed and the flask was rinsed with
serum free M199SE. One milliliter of PBS-HEPES pH 7.5 with 2 mM EDTA was added
to the flask. The flask was floated on liquid nitrogen and stored at –80° C until used.
Frozen cells were scraped from the flask into homogenization buffer, homogenized,
sonicated and separated by differential centrifugation as described in Stegeman et
al.(1995). Pellets were resuspended in buffer (50 mM Tris, pH 7.4, 1 mM dithiothreitol, 1
mM EDTA, 20% glycerol) and frozen in liquid N2 until used. Protein content was
determined using the bicinchoninic acid method, with serum albumin as a standard
(BCA ® Protein Assay Kit, Pierce, Rockland,IL).
3. Immunoblotting  for CYP 1A
The presence of CYP1A was detected by immunoblot analysis of microsomal
preparations as described previously with slight modification (Hahn et al.,1993;
Stegeman et al.,1995). Microsomal protein (30 to 70 µg) and a range of standards of
CYP1A from scup (Stenotomus chrysops) were resolved on a 4-20 % acrylamide
gradient gel in TRIS-glycine with SDS (Jule,Inc, Milford, CT). The proteins were
electrophoretically transferred to a 0.2 µm nitrocellulose membrane (Schleicher &
Schuell, Keene, NH) and incubated with antibody Mab 1-12-3 against scup CYP1A
(Park et al.,1986; Morrison et al.,1995) with secondary antibody linked to horseradish
peroxidase. Mab 1-12-3 strongly recognizes CYP1A1 but not CYP1A2 in mammals.
9Detection was  with the Amersham Enhanced Chemiluminescence Detection Kit using
Kodak X-AR film. The band intensities of the standards and samples were quantified by
video image analysis (NIH Image).
4. EC50  Calculation
EC50,  the inducer concentration producing half maximal induction of EROD
activity, was calculated using the curve fitting routine of Graph Pad Prism for nonlinear
regression sigmoidal dose response. The modified Gaussian equation for EC50 was
described by (Kennedy et al.,1993).
RESULTS:
Cell preparations.
Figure 1 shows cultures of endothelial cells from microvasculature of the kidney
(A,B), capillaries of the rete mirabile (C,D) and the endocardium of the eel heart (E,F).
Each of the cell preparations has a slightly different morphology (Fig 1 B, D, F). At one
time, the cobblestone appearance seen in large vessel cells was considered
characteristic of all endothelial cells but it is now recognized that appearance can vary
for cells from different vessels or with different growth surfaces (Garrick,2000). The
uptake of DiI-Ac-LDL as seen in Fig 1 A, C, and E, confirms that these are endothelial
cells (Garrick,2000).  All of the flasks or plates used for the endothelial cells were
coated with FHA. The heart endocardial cells will grow without FHA but at a much
slower rate and microvascular and capillary cells require fibronectin for growth (Garrick,
2000). We found no difference in the total protein measurement if FHA was present or
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not. The cells in the 48 well plates were intact and viable after treatment with DMSO or
with inducers added in DMSO.
Figure 1 here
Induction of CYP1A activity
The heart, kidney and rete mirabile endothelial cells were plated into 48 well
plates and treated for 48 hours with DMSO, TCDD or βNF as described in the Methods.
The induction medium contained 1% serum to minimize loss of inducer to serum
proteins (Hestermann et al.,2000). At the end of 48 hrs, the EROD activity (CYP1A
activity) and  total protein were measured in each well as described in the Methods and
given in Table 1. The results with each plate are reported in a separate row in Table 1.
In each plate a given concentration of inducer is present in six wells; therefore there is a
sample size of six, except when noted otherwise.
Table 1 here
The results in Table 1 demonstrate that the three types of endothelial cells
respond differently to CYP1A inducers. Both TCDD and βNF induced EROD activity in
the heart endothelial cells. Induction of CYP1A activity by TCDD was much higher in the
heart endocardial cells than in kidney microvascular endothelium. The capillary cells
from the rete mirabile responded minimally or not at all to TCDD or βNF. The basal
levels of EROD activity (DMSO-treated cells) were the same in separate experiments
for each cell type, i.e., 12.7, 5.2 and 0.05 pmol/mg-min for heart, kidney and rete
mirabile, respectively. There was variation in the basal level and amount of enzyme
activity induced by a specific TCDD concentration in different plates of cells for a
specific cell type (Table 1). Variation in results from individual cultures is often seen in
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studies of induction of CYP1A or related enzymatic activities in cells in culture, whether
in endothelial cells, hepatic cells or other types of cells (Farin et al.,1994; Sadar and
Andersson,2001; Tom et al.,2001).
Figure 2 here
EROD rates for all of the samples at a given inducer concentration in different
plates of each type of cell were averaged and plotted in Figures 2A and 2B. Figure 2A
clearly shows the differences in EROD activity of the three types of endothelial cells
after TCDD induction. There is a low level of activity in the endocardial and
microvascular cells with DMSO alone. At the lowest concentration of TCDD (0.01 nM)
the induced enzyme activity in the endocardial cells and the kidney microvascular cells
is similar. EROD activity peaked at 1 nM TCDD in the endocardial cells and then
decreases at 10 nM TCDD. The EROD activity in the kidney microvascular cells
increased with increased concentrations of TCDD with the maximum activity at 0.3 nM
TCDD but the activity (16.1 pmol/mg-min) was much lower than that obtained with the
endocardial cells. Unlike the endocardial and microvascular cells, the capillary cells
from the rete mirabile did not show expression of CYP1A activity with DMSO present.
There was very little if any response from the capillary endothelial cells to TCDD or
βNF.  The EC50 for CYP1A induction by TCDD in heart endothelial cells is 0.013 nM and
in the kidney cells is 0.01 nM.
Treatment of the endocardial cells with βNF induced maximum levels of CYP1A
activity comparable to those obtained with TCDD induction (Fig 2 B). The
concentrations of βNF were higher than those for TCDD (µM vs nM) to produce a
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comparable level of induction. The EROD activity peaked at 3µM βNF and decreased
substantially at 10µM βNF.
Immunochemical Identification of CYP1A
Microsomes were prepared from heart endothelial cells induced with 0.3 µM βNF,
10 µM βNF and 1 nM TCDD for 48 hours in T-75 flasks. These preparations were
chosen to confirm the presence of CYP1A in cells induced with both TCDD and βNF
and that the level of CYP1A will reflect a high or low level of induction of EROD activity
Fig. 3 shows an immunoblot of microsomal protein with the Mab 1-12-3 specific for
CYP1A1 forms in fish (and CYP1A1 in mammals).
Figure 3 here
CYP1A level can be calculated based on the relative densities of the scup
standards and the experimental blot. These are relative values since they are based on
βNF induced scup liver microsomes with antibody Mab 1-12-3 developed against scup
CYP1A. While the antibody reaction is specific for CYP1A the degree of antibody
binding may not be as high with the eel CYP1A as it is for scup. The CYP1A content
was calculated to be 18.5 pmol/mg with 1 nM TCDD induction and 1.41 pmol/mg with
10 µM βNF induction.  The amount of CYP1A in the cells exposed to 0.3 µM βNF was
below the level of detection with loading of 20.4 µg of microsomal protein. The
immunoblots confirm that CYP1A is induced in the eel endothelial cells and the density
of the blots reflect the level of CYP1A present with specific inducer protocols.
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DISCUSSION
Endothelial cells cultured from the vasculature of the eel Anguilla rostrata
respond to the AhR agonists TCDD and βNF with the induction of CYP1A. This
induction is confirmed by increased EROD activity in intact cells and microsomes and
by immunodetection of CYP1A.  However, the three types of endothelial cells respond
to induction differently. Induction of CYP1A is highest in the endocardial cells from
heart, lower in the microvascular cells from the kidney, with little or no induction in the
capillary cells from the rete mirabile. Thus, these cells can respond to AhR agonists in a
way that is specific for each inducer and also specific for each type of endothelial cell.
Are these cells a good model for what occurs in vivo in the endothelial cells?
In many in vivo experiments in teleosts and mammals, the endothelium in some
organs was more responsive than that in other organs to CYP1A induction by AhR
agonists, based on the expression of CYP1A detected immunohistochemically
(Stegeman et al., 1991; Stegeman et al., 1995). Schlezinger and Stegeman (2000a,
2000b) reported organ differences in CYP1A protein expression and activity (EROD) in
extra-hepatic organs of Anguilla rostrata after in vivo induction by xenobiotics and in a
natural population of eels exposed to high levels of PCBs (polychlorinated biphenyls).
The difference in the level of induction in the three endothelial cell populations parallels
the levels Schlezinger and Stegeman(2000a) reported for eel heart, kidney and rete
mirabile after in vivo induction by βNF. There is a consistent pattern of the strongest
EROD activity in the heart and only slight, if any, induction in the capillaries of the rete
mirabile and only with very high doses of inducer. The response in the kidney is
intermediate to the heart and rete mirabile. This same variation in the expression of
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CYP1A was seen when organs were analyzed from eels collected from an environment
contaminated with PCBs (Schlezinger and Stegeman, 2000b). Thus, the cells cultured
from different types of vessels and from different organs in the eel respond differentially
to induction by AhR agonists in a manner similar to that reported in intact animals.
Another species of eel, Anguilla japonica, is reported to have two forms of CYP1A
genes and in these genes there is more than one regulatory element that could play a
role in gene expression (Ogino et al.,1999a; Ogino et al.,1999b). We do not have data
that allow us to extend this information to interpret our results but the possibility of
differential expression of two CYP1As is intriguing.
Until now mammalian endothelial cell cultures have been the cells used for
studies of the cellular response in the vascular system to exposure to AhR agonists
(Farin et al.,1994; Stegeman et al.,1995; Celander et al.,1997; Chat et al.,1998; Thum
et al.,2000; Annas et al.,2000b; Savouret et al.,2001; Hennig et al.,2002a; Borlak et
al.,2003; Ramadass et al.,2003). Although most of the mammalian endothelial cells
have been cultured from large vessels differential responses to AHR agonists have
been reported, for example, between human umbilical artery vs umbilical vein cells,
(Annas et al.,2000b). The peak level of CYP1A1 activity (EROD) after TCDD or βNF
induction in the mammalian large vessel endothelial cells was in the range of 3 to 30
pmol/mg-min (Stegeman et al.,1995; Celander et al.,1997; Annas et al.,2000b). This is
considerably lower than the level we report for induction in the eel heart endocardial
cells and about the same as we report for the kidney microvascular cells.
The EC50, the inducer concentration that produces 50% of maximal EROD
activity, is 0.013 nM TCDD for the heart endothelial cells and 0.01 nM TCDD for the
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kidney endothelial cells. These values are similar to those reported for porcine aortic
endothelial cells, 0.015 nM(Stegeman et al.,1995),  transformed hepatocytes from fish,
0.016-0.022 nM (Hahn et al.,1996) trout gill, 0.04nM (Carlsson and Part,2001) and trout
pituitary cells, 0.017-0.043 nM (Tom et al.,2001). In both the cultured endothelial cells
(Table 1) and in organs taken from Anguilla rostrata (Schlezinger and Stegeman,2000a)
there is a low level of EROD activity when there is no inducer of CYP1A present.
Human aortic endothelial cells (HAEC), but not other mammalian endothelial cells, have
EROD activity without exposure to CYP1A inducers (Celander et al.,1997).
We are not aware of studies that report CYP1A1 activity in intact cells with
cultures of mammalian microvascular or capillary cells to compare to the data with the
eel cells.  Chat et al. (1998) reported a similar level of activity for P450 related enzymes
in microsomes prepared from rat primary microvascular cerebrovascular endothelial
cells (CVEC) and CVEC that had been immortalized (RBE4).  A study that used pieces
of tissue excised from the blood brain barrier of rats localized the induced expression of
CYP1A to the cerebral veins and arteries, with the only activity in capillary endothelium
in the vessels in the choroid plexus (Granberg et al.,2003) . The retention of in vivo
expression of CYP isoforms in mammalian endothelial cells in culture was addressed in
two recent reports. Thum et al. (2000) reported that when rat aortic endothelial cells de-
differentiate there was a dramatic decrease in expression of all major CYP isoforms.
(Chi et al.,2003) reported microarray analysis of 53 endothelial cell cultures that clearly
demonstrated the differences in gene expression in arteries vs veins, large vessels vs
microvascular vessels and in similar types of vessels in different organs. The results we
report demonstrate that cultured eel endothelial cells, like the cultured mammalian cells,
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retain the ability to respond in a selective manner to a specific stimulus such as an AhR
agonist.
Cultures of other extra-hepatic cells from teleosts have been used to study
CYP1A activity.  Rainbow trout gill and pituitary cells show TCDD induced EROD
activity of about 40 and 60 pmol/mg-min, respectively (Thum et al.,2000; Carlsson and
Part,2001; Tom et al.,2001).  We see that the level of EROD activity induced in the eel
endocardial cells  (113 pmol/mg-min, Fig 2 ) ranks high among extra-hepatic tissues
from teleosts.
In summary: 1.) In heart endothelial cells the maximum response to TCDD, 113
pmol/mg-min, occurred at 1 nM TCDD and the peak response to βNF, 135 pmol/mg-
min, at 3 µM βNF. 2.) In kidney endothelial cells the maximum response to TCDD was
12 pmol/mg-min at 0.3 nM TCDD. 3.) The rete mirabile capillary endothelial cells
responded minimally or not at all to exposure to TCDD and βNF. 4.) Both the heart and
kidney endothelial cells had a low level of EROD activity (12.7 and 5.2 pmol/mg-min
respectively) in untreated or DMSO-treated cells. Insignificant activity (0 to 0.05
pmol/mg-min) was detected in untreated or DMSO-treated rete mirabile capillary cells.
The robust response of the heart endothelial cells to AhR agonists gives them
the potential to be an excellent model to investigate the CYP response in vascular cells.
This can be important given the implication of vascular effects in the toxicity of some
AhR agonists. The lack of response in the capillary endothelial cells from the rete
mirabile is also interesting in its specificity. The retention in culture of the differences in
the separate populations of endothelial cells provides the potential to determine the
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mechanisms of induction due to xenobiotics and to also explore the physiological
consequences of these events in different areas of the vasculature.
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FIGURE LEGENDS
Figure 1. Endothelial cells isolated from the microvasculature of the kidney (A,B), the
capillaries of the rete mirabile (C,D) and the endocardium of the heart (E,F) of the eel
Anguilla rostrata. B,D and F are phase contrast micrographs and A,C and E are
fluorescent micrographs showing the uptake of DiI-acetylated-LDL viewed on a Zeiss
Axiovert S100 at 10X
Figure 2. (A) EROD activity induced by TCDD in cultured endothelial cells from the
endocardium of the heart, microvasculature of the kidney and capillaries of the rete
mirabile of the eel.  (B) TCDD and βNF induction in endocardial cells. Note that TCDD
values are in nM and βNF values are in µM. Values are mean + SE of all the values for
a given inducer concentration as listed in Table 1. The EC50 s calculated for the heart
and the kidney endothelial cells for TCDD are 0.013 and 0.01 nM respectively.
Figure 3.  Immunodetection of CYP1A in heart endocardial cells induced for 48 hours as
described in the methods.  (A) Scup control: (B) 0.3 µM βNF, 20.4 µg protein: (C) 10 µM
βNF, 33.6 µg protein: ( D) 1 nM TCDD, 25 µg protein. The CYP1A equivalents were
calculated by comparison to scup βNF - induced liver microsomal preparation with a
range from 0.1 to 0.4 pmol/mg of CYP1A.
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ND=not detectable Values are mean + SE
EC source
nM TCDD 0 0.01 0.1 0.3 1 10 30
Heart 10.8 + 1.6 18.8 + 2.1 70.0 + 6.4 84 + 8.4 43.9 + 12.9
12.1 + 3.9 65.8 + 16 142 + 8.8 132 + 28
Kidney 5.1 + 0.33 10.1 + 0.87 12.2 + 0.64 16.1 + 1.7 11.0 + 0.84 8.1 + 0.88
Rete mirabile *0.05 0.06 0.01 0.08 0.59 0.3
ND ND ND ND ND 4.4 + 7.6
ND ND ND ND
µM βNF 0 1 3 10
Heart 10.8 + 1.6 24.3 + 4.9
12.1 + 3.9 67.5 + 6.7 135.3 + 23.5 17.9 + 4.9
Rete mirabile ND ND ND
pmol/mg/min 
Production of resorufin from 7- ethoxyresorufin in endothelial cells (EC) 
Cells are induced in 48 well plates for 48 hours by TCDD or βNF.
Each row is the result of a separate plate, each value is n = 6 except as noted with *.
pmol/mg/min 
